Global Apheresis Market Report and Forecast 2023-2031
Global Apheresis Market Outlook
The global market value in 2022 was about USD 2.45 billion and is anticipated be driven by the growing demand for blood components for transfusion across the globe. The global apheresis market share is anticipated to grow at a CAGR of 9.2% during the forecast period of 2023-2031 to achieve a value of USD 5.40 billion by 2031.
Apheresis: Introduction
Apheresis is a medical procedure that involves the separation and removal of specific components from blood, such as plasma, platelets, red blood cells, or white blood cells, while the remaining components are returned to the patient or donor. Apheresis is primarily used to collect specific blood components for transfusion, for the treatment of certain medical conditions, and to remove harmful substances from the blood in patients with specific diseases.
Apheresis Market Scenario
The global apheresis market has witnessed significant growth in recent years, driven by factors such as the increasing prevalence of chronic diseases, the growing demand for blood components for transfusion, and advancements in apheresis technology.
North America: The largest market for apheresis, driven by factors such as the advanced healthcare infrastructure, high prevalence of chronic diseases, and significant investments in apheresis research and development.
Europe: The second-largest market, with increasing demand for apheresis due to a growing aging population, a supportive regulatory framework, and an expanding healthcare sector.
Asia Pacific: Expected to witness the highest growth rate due to factors such as a rapidly growing population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure and research.
Apheresis Market Segmentations
Market Breakup by Product
Market Breakup by Technology
- Centrifugation
- Membrane Separation
Market Breakup by Procedure
- Plasmapheresis
- Leukapheresis
- Erythrocytapheresis
- Plateletpheresis
- Others
Market Breakup by Application
- Renal Disease
- Hematological Disease
- Autoimmune Disease
- Neurological Disease
- Others
Market Breakup by End User
- Blood Collection Centers and Blood Component Providers
- Hospitals and Transfusion Centers
- Others
Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Trends in the Apheresis Market
Some key trends of the market are as follows:
- Increasing prevalence of chronic diseases: The rising incidence of chronic diseases, such as cancer, autoimmune diseases, and blood disorders, has led to a growing demand for apheresis procedures, driving market growth.
- Growing demand for blood components for transfusion: The increasing need for blood components, such as platelets and plasma, for transfusion in the treatment of various medical conditions has contributed to the growth of the apheresis market.
- Advancements in apheresis technology: The development of new apheresis techniques and devices, such as automated and continuous flow systems, has improved the efficiency and safety of apheresis procedures, further driving market growth.
Apheresis Market: Competitor Landscape
The report gives an in-depth analysis of the key players involved in the apheresis market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
- Nikkiso Co., Ltd.
- Asahi Kasei Medical Co. Ltd
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Terumo Bct, Inc
- Haemonetics Corporation
- Mallinckrodt
- Kaneka Corporation
- Kawasumi Laboratories, Inc.
- Miltenyi Biotec
- Infomed
- Toray Medical Co., Ltd.
*Please Note:* The report will be completed in 7 business days after order confirmation